Evidence map›Paper›PMID 39472981›Full record

ArticleAnnals of clinical microbiology and antimicrobials2024

Clinical characteristics of patients with granulomatous lobular mastitis associated with Corynebacterium parakroppenstedtii infection and drug sensitivity analysis of the isolated strains.

Yifei Zeng, Mengjie Wang, Xiang Gao, Dongxiao Zhang, Na Fu, Wenjie Zhao, Qiao Huang

Abstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Emerging Insights intoInfection and drug resistance · 2025
    Article
  6. Emerging mastitis-associatedFrontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yifei ZengDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Mengjie WangDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Xiang GaoDepartment of Clinical Laboratory Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Dongxiao ZhangDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China. morningdong@163.com.
Na FuDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Wenjie ZhaoDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Qiao HuangDepartment of Galactophore, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is presently considered that Corynebacterium especially Corynebacterium kroppenstedtii (CK) infection, is one of the important causes of granulomatous lobular mastitis (GLM). However, the pathogen of mastitis in the past two years has been identified as a newly discovered Corynebacterium. But it is unclear whether the pathogen associated with the occurrence of GLM is also this bacterium.

methodsGLM female patients with positive bacterial culture in pus specimens from February 2023 to February 2024 who were identified as CK infection by mass spectrometer were selected as the research objects in this study, and the clinical isolates were identified by 16S rDNA sequencing technology to identify the specific pathogen of GLM-related bacterial infection. Subsequently, the clinical characteristics of the patients were compared with those of GLM patients without bacterial infection during the same period, to explore the effect of this particular type of Corynebacterium infection on disease development in GLM patients. Finally, we tested the minimum inhibitory concentration (MIC) values of antibiotics when inhibiting these separation strains in vitro through the E-Test experiment, to evaluate their medicine sensitivity.

resultsA total of 31 GLM patients initially diagnosed with Corynebacterium kroppenstedtii (CK) infection via MALDI-TOF MS were enrolled in the study. However, subsequent 16S rDNA sequencing revealed that 28 isolates (90.32%) were actually identified as the newly recognized Corynebacterium parakroppenstedtii (CPK). This discovery challenges the conventional belief that CK is the primary pathogen of GLM, suggesting instead that CPK is the predominant pathogen associated with GLM bacterial infections. Comparative analysis of the clinical characteristics between the two groups revealed a significantly higher recurrence rate among CPK-infected GLM patients compared to those without CPK infection, along with elevated prolactin levels (P < 0.05). The sensitivity test results indicated high sensitivity of the isolates to vancomycin, linezolid, and rifampicin.

conclusionIn conclusion, this study highlights that Corynebacterium kroppenstedtii strains isolated from GLM specimens were Corynebacterium parakroppenstedtii, serving as the primary pathogen closely linked to GLM's occurrence. CPK infection significantly increases the risk of recurrence in GLM patients, with elevated prolactin levels potentially playing a pivotal role in this process. In clinical antimicrobial treatment, antimicrobials other than penicillin and ciprofloxacin may be empirically administered when sensitivity test results are inconclusive.

Indexed as

Anti-Bacterial AgentsCorynebacteriumCorynebacterium InfectionsGranulomatous MastitisMicrobial Sensitivity TestsRNA, Ribosomal, 16SAdultDNA, BacterialFemaleHumansMiddle AgedAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 16SAntimicrobial sensitivityBacterial infectionCorynebacterium kroppenstedtiiCorynebacterium ParakroppenstedtiiGranulomatous lobular mastitisPathogensRecurrence

Identifiers

PMID39472981
PMCPMC11520474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.